Document is current

Article History

Accepted: 25 October 2023

First Online: 16 November 2023

Declarations

:

: This study was conducted by employees of the Dutch Medicines Evaluation Board. There was no external funding source for the conduct of this study.

: Sieta T. de Vries, Noral Huda S. Al-Mugoter, Irena Petkoska, Stefan Verweij, André J.A. Elferink and Peter G.M. Mol were affiliated to a regulatory authority at the time of the study conduct.

: No ethics approval was necessary for this study in which publicly available information was used.

: Not applicable.

: Not applicable.

: The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.

: Not applicable.

: STdV, NHSAM, AJAE and PGMM contributed to the development and formulation of the research question. NHSAM and IP conducted the manual search and analyses. SW retrieved the search terms from the regulatory documents. All authors contributed to the interpretation of the data. STdV drafted the manuscript. All other authors critically reviewed and edited the manuscript. All authors had full access to all the data in the study and have read and approved the final manuscript. PGGM is responsible for the overall content as the guarantor.

: The views expressed in this article are the personal views of the authors and may not be understood or quoted as being made on behalf of, or reflecting the position of the Dutch Medicines Evaluation Board or one of its committees.